Vincerx Pharma Inc (VINC)
0.2982
-0.03
(-8.25%)
USD |
NASDAQ |
Nov 14, 12:20
Vincerx Pharma Total Liabilities (Quarterly): 6.079M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 6.079M |
| March 31, 2024 | 11.70M |
| December 31, 2023 | 6.995M |
| September 30, 2023 | 10.54M |
| June 30, 2023 | 11.14M |
| March 31, 2023 | 12.98M |
| December 31, 2022 | 11.62M |
| September 30, 2022 | 12.67M |
| Date | Value |
|---|---|
| June 30, 2022 | 13.38M |
| March 31, 2022 | 14.71M |
| December 31, 2021 | 17.36M |
| September 30, 2021 | 28.80M |
| June 30, 2021 | 19.54M |
| March 31, 2021 | 32.45M |
| December 31, 2020 | 37.81M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
6.079M
Minimum
Jun 2024
37.81M
Maximum
Dec 2020
16.52M
Average
12.98M
Median
Mar 2023
Total Liabilities (Quarterly) Benchmarks
| CEL-SCI Corp | 15.60M |
| AIM ImmunoTech Inc | 9.613M |
| IGC Pharma Inc | 2.714M |
| NovaBay Pharmaceuticals Inc | 4.542M |
| Protalix BioTherapeutics Inc | 62.96M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 21.53M |
| Shareholders Equity (Quarterly) | 15.45M |